573 results on '"Kosaka, Takeo"'
Search Results
2. Aggressive variant prostate cancer with multiple subcutaneous metastases: a case report
3. Vasohibin-1 Expression Can Predict Pathological Complete Remission of Advanced Bladder Cancer with Neoadjuvant Chemotherapy
4. Risk factors for postoperative fever after laparoscopic adrenalectomy focusing on hormones produced: a case control study
5. Prediction of pathological up-staging after radical nephroureterectomy in patients with upper tract urothelial carcinoma
6. Anemia in patients ≥ 75 years with metastatic clear cell renal cell carcinoma: an important poor prognostic factor in the international metastatic renal cell carcinoma database consortium model
7. MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells
8. Prognostic impact of tumor ureteral invasion on recurrence after radical cystectomy
9. Long-Term Prognosis and Treatment Strategy of Persistent PSA After Radical Prostatectomy
10. Detection of the Highest-Grade Lesion in Multifocal Discordant Prostate Cancer by Multiparametric Magnetic Resonance Imaging
11. Factors affecting the selection of eligible candidates for focal therapy for prostate cancer
12. Prognostic role of the innate immune signature CD163 and “eat me” signal calreticulin in clear cell renal cell carcinoma
13. Strategy for PSA progression in patients undergoing salvage radiation for biochemical recurrence after radical prostatectomy
14. Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma
15. The sialyl-Tn antigen synthase genes regulates migration–proliferation dichotomy in prostate cancer cells under hypoxia
16. Discovery of a new candidate drug to overcome cabazitaxel-resistant gene signature in castration-resistant prostate cancer by in silico screening
17. Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series
18. A low subcutaneous fat mass is a risk factor for the development of inguinal hernia after radical prostatectomy
19. Site-Specific Differences in PD-1 Blockade Success and Biomarkers in Urothelial Carcinoma Treated with Pembrolizumab
20. Hybridisation chain reaction-based visualisation and screening for lncRNA profiles in clear-cell renal-cell carcinoma
21. Multiple metastases of androgen indifferent prostate cancer in the urinary tract: two case reports and a literature review
22. A Japanese case of castration-resistant prostate cancer with BRCA2 and RB1 co-loss and TP53 mutation: a case report
23. Castration-resistant prostate cancer patient presenting with whole genome doubling with CDK-12 mutation
24. Current issues and management consensus of advanced prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference—JAPAN 2023.
25. Efficacy of trametinib in a metastatic urothelial carcinoma patient with a BRAF mutation.
26. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements
27. A novel mechanism of thrombocytopenia by PS exposure through TMEM16F in sphingomyelin synthase 1 deficiency
28. Negative impact of neoadjuvant hormonal therapy on detecting biochemical recurrence after radical prostatectomy
29. On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma
30. Evaluation of Gleason Grade Group 5 in a Contemporary Prostate Cancer Grading System and Literature Review
31. A first Japanese case of BRCA2 and RB1 co-loss organ-confined prostate cancer successfully treated by radical prostatectomy
32. A long-term survivor of metastatic neuroendocrine prostate cancer treated with multimodal therapy: genetic consideration from next-generation sequencing
33. Long-term follow-up comparing salvage radiation therapy and androgen-deprivation therapy for biochemical recurrence after radical prostatectomy
34. Can random bladder biopsies be eliminated after bacillus Calmette–Guérin therapy against carcinoma in situ?
35. The incidences of metachronous multiple gastric cancer after various types of gastrectomy: analysis of data from a nationwide Japanese survey
36. A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations
37. Utility of prophylactic antibiotics for preventing febrile neutropenia during cabazitaxel therapy for castration-resistant prostate cancer
38. Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer
39. CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer
40. Topoisomerase II alpha inhibition can overcome taxane-resistant prostate cancer through DNA repair pathways
41. TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells
42. External validation of the "optimal PSA follow-up schedule after radical prostatectomy” in a new cohort
43. Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy
44. Impact of prostatic shape on the difficulty of robot‐assisted laparoscopic radical prostatectomy.
45. Prognostic Value of Baseline Serum C-Reactive Protein Level in Intermediate-Risk Group Patients With Metastatic Renal-Cell Carcinoma Treated by First-Line Vascular Endothelial Growth Factor–Targeted Therapy
46. Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
47. Purified Protein Derivative Skin test prior to bacillus Calmette-Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer
48. Change of the 5α/5β ratio of urinary steroid metabolites in benign prostatic hyperplasia patients treated with dutasteride
49. Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients
50. Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.